To recapitulate progression to BC in an unbiased in vivo setting, Giotopoulos et al combined the SCLtTA/BCR-ABL double transgenic model with a transposon-based insertional mutagenesis system to generate a murine model of CML progression [63]. This evidence concerns the gene BCR and breast cancer.